NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.
— Summary
BUSINESS
visit smh.com.au
smh.com.au
NeuroScientific specialist hire sets stage for major Crohn’s trial
